Please Wait

Applying Filters...

Drug Product Composition: PIPERACILLIN; TAZOBACTAM

PIPERACILLIN; TAZOBACTAM

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

36 API Suppliers, 14 USDMF, 13 CEP/COS, 13 JDMF, 3 EU WC, 13 KDMF, 14 NDC API, 8 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

164 FDF Dossiers, 67 FDA Orange Book, 53 Europe, 13 South Africa, 31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML, INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML, INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 1 Actylis, 4 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Fillers, Diluents & Binders, 1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 51 Finished Drug Prices, 5 Annual Reports

MARKET PLACE

5 APIs, 5 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 7 Others

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 50750 / DOSAGE - INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
PIPERACILLIN SODIUM(UNII: M98T69Q7HP) (PIPERACILLIN ANHYDROUS - UNII:9I628532GX)	PIPERACILLIN ANHYDROUS	4g in 100 \| 3g in 50 \| 2g in 50
TAZOBACTAM SODIUM(UNII: UXA545ABTT) (TAZOBACTAM - UNII:SE10G96M8W)	TAZOBACTAM	500mg in 100 \| 375mg in 50 \| 250mg in 50

Inactive Ingredients

Ingredient Name	Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.	Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
DEXTROSE MONOHYDRATE(LX22YL083G)
EDETATE DISODIUM(7FLD91C86K)
HYDROCHLORIC ACID(QTT17582CB)
SODIUM BICARBONATE(8MDF5V39QO)
SODIUM CITRATE(1Q73Q2JULR)
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR)
WATER(059QF0KO0R)

Drug Product Composition: PIPERACILLIN; TAZOBACTAM

PIPERACILLIN; TAZOBACTAM

PIPERACILLIN; TAZOBACTAM

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

36 API Suppliers

14 USDMF

13 CEP/COS

13 JDMF

3 EU WC

13 KDMF

14 NDC API

8 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

FINISHED DOSAGE FORMULATIONS

164 FDF Dossiers

67 FDA Orange Book

53 Europe

13 South Africa

31 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 40MG BASE/ML;EQ 5MG BASE/ML

INJECTABLE;INJECTION - EQ 4GM BASE/100ML;EQ 500MG BASE/100ML

INJECTABLE;INJECTION - EQ 60MG BASE/ML;EQ 7.5MG BASE/ML

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

1 Actylis

4 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral

2 Fillers, Diluents & Binders

1 API Stability Enhancers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

30 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

51 Finished Drug Prices

5 Annual Reports

MARKET PLACE

5 APIs

5 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM

2 USP

7 Others

Filters

INJECTABLE;INJECTION - EQ 2GM BASE/VIAL;EQ 250MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 3GM BASE/VIAL;EQ 375MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons